EU Approval Decision Delay For BMS’s Ozanimod

Company Needed More Time To Answer Questions On New MS Product

 
• By Maureen Kenny
  
Question marks
Companies sometime ask for extra time to address regulators' questions • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography